title: Capillary and aortic endothelia interact in situ with nonenzymatically glycated albumin and develop specific alterations in early experimental diabetes.
abstract: Diabetic mice (6 weeks duration) were studied to assess the interaction of advanced glycation endproduct-modified albumin (AGE-Alb) with micro- and macrovascular endothelium, and to evaluate the alterations induced in the ultrastructure of the lung, kidney, and aorta. [125I]-AGE-Alb and AGE-Alb-Au were perfused in situ in the vasculature; the total uptake was quantitated by spectrometry, and the endothelial pathways of AGE-Alb-Au and the morphological alterations of the vascular beds were examined by electron microscopy. The results showed that [125I]-AGE-Alb (0.567 microM) was taken up specifically and saturably by all organs studied, and particularly by the lung. AGE-Alb-Au endocytosis and transcytosis occurred in the pulmonary and aortic endothelia, and were enhanced in diabetic animals. Also in diabetic animals, AGE-Alb-Au was detected throughout the kidney glomerular basement membrane (GBM) and within open filtration slits of podocytes, suggesting altered barrier function. The structural modifications progressed, and at the end of the experimental period, in the lung approximately 28% of the capillaries and approximately 25% of the alveoli became compressed or even collapsed, due to the hyperplasia of extracellular matrix and interstitial connective tissue. The presence of adherent intravascular macrophages suggests the development of an inflammatory immune process. The structural modifications observed in kidney glomeruli included thickening (approximately 30%) of the GBM and the disappearance of diaphragms between the cellular processes of podocytes. The aortic endothelium displayed luminal foldings, increased number (2.8-fold) of Weibel-Palade bodies, and proliferation of basal lamina. Together, the results show that in diabetes there is enhanced vascular uptake of AGE-Alb and significant pathomorphological changes of micro- and macrovessels.
authors.affiliation: Institute of Cellular Biology and Pathology Nicolae Simionescu, Bucharest, Romania.
authors.forename: D
authors.initials: D
authors.lastname: Popov
authors.forename: M
authors.initials: M
authors.lastname: Hasu
authors.forename: G
authors.initials: G
authors.lastname: Costache
authors.forename: D
authors.initials: D
authors.lastname: Stern
authors.forename: M
authors.initials: M
authors.lastname: Simionescu
mesh_terms: D000818:Animals; D001011:Aorta; D002196:Capillaries; D015331:Cohort Studies; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism* / Q000473:pathology; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism* / Q000473:pathology; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000473:pathology / Q000648:ultrastructure; D017127:Glycation End Products, Advanced / Q000378:metabolism*; D006031:Glycosylation; D066298:In Vitro Techniques; D007457:Iodine Radioisotopes; D007668:Kidney / Q000098:blood supply / Q000473:pathology; D008168:Lung / Q000098:blood supply / Q000473:pathology; D008297:Male; D051379:Mice; D010477:Perfusion; D012709:Serum Albumin / Q000032:analysis / Q000378:metabolism*
chemical_list: D017127:Glycation End Products, Advanced; D007457:Iodine Radioisotopes; D012709:Serum Albumin